ArticleGene therapy2012

Absence of ocular malignant transformation after sub-retinal delivery of rAAV2/2 or integrating lentiviral vectors in p53-deficient mice.

K S Balaggan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.